Skip to content

Clinical trials

Phase 3 Skin Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Skin Diseases Phase: Phase 3 Country / region: Germany Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20103
20111
20121
20132
20151
20183
20191
20203
20212
20236
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting3
Recruiting2
Withdrawn2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation6
Amgen4
Eli Lilly and Company4
Pfizer4
MoonLake Immunotherapeutics AG3
Novartis Pharmaceuticals3
Almirall, S.A.2
AstraZeneca1
Coloplast A/S1
Galderma R&D1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Skin Diseases29
Dermatitis11
Eczema8
Dermatitis, Atopic6
Hidradenitis Suppurativa5
Psoriasis5
Pruritus4
Arthritis3
Arthritis, Psoriatic3
Hidradenitis3

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.